Assessing Whether Biodexa Pharmaceuticals Plc ADR (NASDAQ: BDRX) Is Over- Or Undervalued
Biodexa Pharmaceuticals Plc ADR (BDRX) concluded trading on Thursday at a closing price of $4.40, with 5.81 million shares of worth about $25.56 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -84.00% during that period and on November 21, 2024 the price saw […]
Is There More Upside Ahead For Biodexa Pharmaceuticals Plc ADR (NASDAQ: BDRX)
Biodexa Pharmaceuticals Plc ADR (BDRX) concluded trading on Wednesday at a closing price of $8.40, with 7.29 million shares of worth about $61.25 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -60.49% during that period and on October 16, 2024 the price saw […]
Tomorrow Is Not Likely To Be Same For Biodexa Pharmaceuticals Plc ADR (BDRX)
Biodexa Pharmaceuticals Plc ADR (BDRX) concluded trading on Thursday at a closing price of $0.29, with 2.85 million shares of worth about $0.83 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -65.66% during that period and on September 26, 2024 the price saw […]
Set Your Sights On Biodexa Pharmaceuticals Plc ADR (NASDAQ: BDRX)’S Upside Potential
Biodexa Pharmaceuticals Plc ADR (BDRX) concluded trading on Wednesday at a closing price of $1.35, with 9.32 million shares of worth about $12.58 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -78.57% during that period and on Wednesday February 7 the price saw […]
